Insights

Optimizing Covid-19 isolation: the role of virus testing and the technology requirements

As work, education and recreation resume following Covid-19 restrictions, further isolation regimes must be proportionate, effective and properly supported by technology...

Diagnostics consumables Immunodiagnostics Point of care diagnostics Technologies

Optimizing Covid-19 isolation: the role of virus testing and the technology requirements

As work, education and recreation resume following Covid-19 restrictions, further isolation regimes must be proportionate, effective and properly supported by technology...

Diagnostics consumables Immunodiagnostics Point of care diagnostics Technologies

With the beauty tech movement rapidly gathering momentum, it’s easy to be swept along by the crowd. But to achieve lasting success and competitive differentiation, brands need...
In a recent webinar, Erica Kantor, Sagentia and Dr Eileen Buttimer, Oakland Innovation, explored the changing world of...
In recent years, the landscape of the food and beverage industry has been changing, seeing a rise in reduced fat...
Last week Rob Morgan and Carl Hewett took part in the MD +DI virtual event series How the MedTech Industry can respond...
Panel: Simon Norman, Head of Product Development – Food and Beverage – Leatherhead Food Research Carla Hilhorst...
It’s clear that consumers are increasingly expecting products to be more adaptable and tailored to their individual...
The historic lack of funding and research in female health and wellness has led to a corresponding gap in data. We...
Diagnostic product development advice from Sagentia’s Nick Collier and Carl Hewett Continued innovation in Point of...
From SARS-CoV-2 to cardiac biomarkers, a steady stream of IVD innovation shows no signs of letting up Article published...
By Chris Humby, Vice-President Medical at Sagentia Statistics surrounding chronic kidney disease (CKD) make sobering...
Article Featured in Diagnostics World by Dr. Nick Collier and Carl Hewett Point of care (PoC) testing offers many...
Failure to scale-up testing will exacerbate the challenge As it stands, most people with symptoms will not be tested...
Get in touch